| Literature DB >> 33285890 |
Martín Calderón-Juárez1, Gertrudis Hortensia González-Gómez2, Juan C Echeverría3, Héctor Pérez-Grovas4, Claudia Lerma5.
Abstract
Linear heart rate variability (HRV) indices are dependent on the mean heart rate, which has been demonstrated in different models (from sinoatrial cells to humans). The association between nonlinear HRV indices, including those provided by recurrence plot quantitative analysis (RQA), and the mean heart rate (or the mean cardiac period, also called meanNN) has been scarcely studied. For this purpose, we analyzed RQA indices of five minute-long HRV time series obtained in the supine position and during active standing from 30 healthy subjects and 29 end-stage renal disease (ESRD) patients (before and after hemodialysis). In the supine position, ESRD patients showed shorter meanNN (i.e., faster heart rate) and decreased variability compared to healthy subjects. The healthy subjects responded to active standing by shortening the meanNN and decreasing HRV indices to reach similar values of ESRD patients. Bivariate correlations between all RQA indices and meanNN were significant in healthy subjects and ESRD after hemodialysis and for most RQA indices in ESRD patients before hemodialysis. Multiple linear regression analyses showed that RQA indices were also dependent on the position and the ESRD condition. Then, future studies should consider the association among RQA indices, meanNN, and these other factors for a correct interpretation of HRV.Entities:
Keywords: active standing; heart rate variability; hemodialysis; recurrence plot analysis
Year: 2020 PMID: 33285890 PMCID: PMC7516420 DOI: 10.3390/e22010114
Source DB: PubMed Journal: Entropy (Basel) ISSN: 1099-4300 Impact factor: 2.524
Figure 1Assessment of the autocorrelation function (upper panels) and false nearest neighbors method (lower panels) for each recording (thin lines) and averaged values per group (thick lines). Black lines correspond to healthy subjects, green lines correspond to ESRD patients before hemodialysis, and magenta lines correspond to ESRD patients after hemodialysis.
Figure 2Examples of RR time series and recurrence plots from a healthy subject (upper panels) and an end-stage renal disease (ESRD) patient (lower panels). The recording from the healthy subject shows a reduction in RR intervals and their variability, as a consequence of changing to an active standing position. The recurrence plot shows extended global diagonal lines formed by short diagonals covering a regularly spaced pattern of the plot surface. In contrast, during the standing position, there is an increase in white zones (i.e., there are less accessible dynamic states in the central area). In the patient before hemodialysis, there is a marked reduction in the RR intervals and their associated variability, even in the supine position. Its recurrence plot quantitative analysis (RQA) plot has less regularly extended diagonals with more concentration around the identity line and its parallel lines. During the active standing condition, the plot is almost empty; there are very fewer accessible dynamical states. In the same patient after hemodialysis, there is a slight improvement in the RR intervals during the supine condition compared to those before hemodialysis, which is also reflected in the RQA plot. Again, during the active standing challenge, there is a reduction in RR intervals and reachable dynamical states.
Heart rate variability indices evaluated in 30 healthy subjects and 29 end-stage renal disease (ESRD) patients undergoing hemodialysis treatment regularly. Data are shown as mean ± standard deviation. HF: high frequency, LF: low frequency, meanNN: mean cardiac period.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | |
|---|---|---|---|
| Supine position | |||
| Statistical indices | |||
| meanNN (ms) | 0.904 ± 0.115 * | 0.754 ± 0.106 *, & | 0.740 ± 0.143 *, & |
| SDNN (ms) | 0.058 ± 0.022 * | 0.024 ± 0.012 & | 0.025 ± 0.011 & |
| SDSD (ms) | 0.051 ± 0.021 * | 0.016 ± 0.013 & | 0.016 ± 0.012 & |
| pNN50 (%) | 67.2 ± 15.4 * | 17.3 ± 19.4 & | 20.6 ± 22.8 *, & |
| Spectral indices | |||
| LF (n.u.) | 56.7 ± 20.7 * | 70.5 ± 20.1 & | 66.5 ± 20.0 * |
| HF (n.u.) | 43.8 ± 19.5 * | 30.1 ± 19.5 *, & | 33.7 ± 20.4 * |
| LF/HF | 2.39 ± 3.52 * | 4.88 ± 6.62 | 4.85 ± 7.50 |
| Ln (LF/HF) | 0.316 ± 0.990 * | 1.025 ± 1.082 *, & | 0.880 ± 1.138 * |
| Active standing | |||
| Statistical indices | |||
| meanNN (ms) | 0.733 ± 0.112 | 0.717 ± 0.112 | 0.616 ± 0.116 &, ¶ |
| SDNN (ms) | 0.046 ± 0.021 | 0.029 ± 0.012 & | 0.026 ± 0.022 & |
| SDSD (ms) | 0.025 ± 0.010 | 0.016 ± 0.013 & | 0.013 ± 0.014 & |
| pNN50 (%) | 41.0 ± 17.9 | 17.8 ± 19.4 & | 12.9 ± 19.9 & |
| Spectral indices | |||
| LF (n.u.) | 77.0 ± 15.1 | 76.4 ± 16.9 | 77.8 ± 14.7 |
| HF (n.u.) | 23.3 ± 15.1 | 23.6 ± 16.9 | 23.4 ± 15.5 |
| LF/HF | 6.32 ± 8.45 | 6.65 ± 6.89 | 6.20 ± 5.48 |
| Ln (LF/HF) | 1.391 ± 0.927 | 1.421 ± 1.030 | 1.423 ± 0.935 |
* p < 0.05 supine position vs. active standing (same group). & p < 0.05 ESRD group (either before hemodialysis or after hemodialysis) vs. healthy group (same position). ¶ p < 0.05 before hemodialysis vs. after hemodialysis (same position).
Recurrence quantification analysis (RQA) indices of heart rate variability evaluated in 30 healthy subjects and 29 end-stage renal disease (ESRD) patients undergoing hemodialysis treatment. Data are shown as mean ± standard deviation. The recurrence plots were reconstructed with the subgroup embedding time delays as described in the Methods section.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | |
|---|---|---|---|
| Supine position | |||
| Determinism | 0.384 ± 0.135 * | 0.447 ± 0.169 | 0.446 ± 0.182 * |
| Mean diagonal length | 2.455 ± 0.259 | 2.535 ± 0.433 | 2.513 ± 0.395 * |
| Longest diagonal line | 16.884 ± 9.148 | 12.420 ± 10.048 | 14.288 ± 21.322 |
| Entropy | 0.790 ± 0.222 * | 0.872 ± 0.338 | 0.864 ± 0.351 * |
| Laminarity | 0.410 ± 0.199 * | 0.553 ± 0.162 & | 0.551 ± 0.182 *,& |
| Trapping time | 2.308 ± 0.234 * | 2.697 ± 0.486 *, & | 2.709 ± 0.524 *, & |
| Longest vertical line | 6.868 ± 2.714 * | 9.354 ± 2.913 & | 9.514 ± 3.479 *, & |
| Recurrence time type 1 | 14.120 ± 1.500 | 15.734 ± 1.571 & | 15.975 ± 1.985 & |
| Recurrence time type 2 | 19.631 ± 4.885 * | 26.856 ± 7.351 *, & | 27.683 ± 9.075 *, & |
| Active standing | |||
| Determinism | 0.541 ± 0.159 | 0.506 ± 0.197 | 0.530 ± 0.193 |
| Mean diagonal length | 2.618 ± 0.316 | 2.661 ± 0.552 | 2.843 ± 0.736 |
| Longest diagonal line | 19.669 ± 11.931 | 11.626 ± 10.425 & | 14.144 ± 11.671 |
| Entropy | 0.991 ± 0.284 | 0.980 ± 0.437 | 1.128 ± 0.437 |
| Laminarity | 0.650 ± 0.147 | 0.610 ± 0.183 | 0.629 ± 0.170 |
| Trapping time | 2.827 ± 0.391 | 2.921 ± 0.618 & | 3.157 ± 0.696 &, ¶ |
| Longest vertical line | 10.135 ± 2.822 | 9.810 ± 2.773 | 12.208 ± 3.850 &, ¶ |
| Recurrence time type 1 | 14.985 ± 1.256 | 15.555 ± 1.769 | 15.322 ± 2.677 |
| Recurrence time type 2 | 28.644 ± 7.399 | 30.858 ± 10.643 | 31.259 ± 10.295 |
* p < 0.05 supine position vs. active standing (same group). & p < 0.05 ESRD group (either before hemodialysis or after hemodialysis) vs. healthy group (same position). ¶ p < 0.05 before hemodialysis vs. after hemodialysis (same position).
Recurrence quantification analysis (RQA) indices of HRV evaluated in 30 healthy subjects and 29 end-stage renal disease (ESRD) patients under maintenance hemodialysis. Data are shown as mean ± standard deviation. The recurrence plots were reconstructed with the overall embedding time delay = 8.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | |
|---|---|---|---|
| Supine position | |||
| Determinism | 0.326 ± 0.126 * | 0.459 ± 0.167 *, & | 0.457 ± 0.180 *, & |
| Mean diagonal length | 2.311 ± 0.164 | 2.587 ± 0.493 *, & | 2.625 ± 0.473 *, & |
| Longest diagonal line | 7.868 ± 4.299 | 16.323 ± 12.944 | 20.953 ± 26.398 *, & |
| Entropy | 0.669 ± 0.219 * | 0.912 ± 0.327 *, & | 0.952 ± 0.351 *, & |
| Laminarity | 0.388 ± 0.194 * | 0.560 ± 0.160 *, & | 0.566 ± 0.175 *, & |
| Trapping time | 2.283 ± 0.222 * | 2.750 ± 0.528 *, & | 2.759 ± 0.577 *, & |
| Longest vertical line | 5.996 ± 2.134 * | 9.687 ± 2.941 *, & | 9.740 ± 3.664 *, & |
| Recurrence time type 1 | 15.102 ± 1.629 | 15.253 ± 1.572 | 15.174 ± 1.716 * |
| Recurrence time type 2 | 20.602 ± 4.642 * | 26.295 ± 7.725 *, & | 26.717 ± 9.258 *, & |
| Active standing | |||
| Determinism | 0.532 ± 0.142 | 0.538 ± 0.202 | 0.574 ± 0.194 |
| Mean diagonal length | 2.564 ± 0.281 | 2.867 ± 0.734 | 3.212 ± 1.084 & |
| Longest diagonal line | 13.598 ± 8.832 | 22.361 ± 18.974 | 30.540 ± 21.585 & |
| Entropy | 0.960 ± 0.268 | 1.095 ± 0.446 | 1.284 ± 0.517 & |
| Laminarity | 0.643 ± 0.140 | 0.630 ± 0.195 | 0.663 ± 0.169 |
| Trapping time | 2.787 ± 0.377 | 3.083 ± 0.744 | 3.445 ± 0.925 & |
| Longest vertical line | 9.538 ± 2.933 | 11.029 ± 3.431 | 13.910 ± 4.169 &, ¶ |
| Recurrence time type 1 | 15.311 ± 1.374 | 14.831 ± 1.299 | 14.230 ± 2.069 & |
| Recurrence time type 2 | 28.748 ± 7.125 | 30.646 ± 11.924 | 31.079 ± 10.214 |
* p < 0.05 supine position vs. active standing (same group). & p < 0.05 ESRD group (either before hemodialysis or after hemodialysis) vs. healthy group (same position). ¶ p < 0.05 before hemodialysis vs. after hemodialysis (same position).
RQA indices of HRV evaluated in 30 healthy subjects and 29 end-stage renal disease (ESRD) patients undergoing hemodialysis treatment regularly. Data are shown as mean ± standard deviation. The recurrence plots were reconstructed with ad hoc embedding time delays estimated for each time series, as described in the Methods section.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | |
|---|---|---|---|
| Supine position | |||
| Determinism | 0.622 ± 0.251 | 0.538 ± 0.195 | 0.495 ± 0.210 |
| Mean diagonal length | 3.806 ± 1.263 * | 3.048 ± 1.060 & | 2.831 ± 0.856 & |
| Longest diagonal line | 22.199 ± 10.200 | 20.885 ± 15.643 | 20.108 ± 25.741 |
| Entropy | 1.548 ± 0.735 * | 1.165 ± 0.581 | 1.047 ± 0.524 & |
| Laminarity | 0.407 ± 0.221 * | 0.576 ± 0.152 & | 0.550 ± 0.183 & |
| Trapping time | 2.351 ± 0.219 * | 2.771 ± 0.548 *, & | 2.738 ± 0.579 * & |
| Longest vertical line | 8.118 ± 3.113 * | 10.099 ± 2.505 & | 9.626 ± 3.054 * |
| Recurrence time type 1 | 14.010 ± 1.727 | 15.051 ± 2.056 | 15.361 ± 2.578 |
| Recurrence time type 2 | 19.565 ± 5.278 * | 26.515 ± 8.023 & | 27.053 ± 10.137 & |
| Active standing | |||
| Determinism | 0.593 ± 0.156 | 0.567 ± 0.198 | 0.503 ± 0.195 |
| Mean diagonal length | 3.100 ± 0.831 | 2.962 ± 0.805 | 2.770 ± 0.572 |
| Longest diagonal line | 24.676 ± 14.212 | 22.190 ± 20.301 | 14.261 ± 11.132 & |
| Entropy | 1.191 ± 0.451 | 1.196 ± 0.490 | 1.065 ± 0.413 |
| Laminarity | 0.663 ± 0.153 | 0.623 ± 0.181 | 0.610 ± 0.172 |
| Trapping time | 2.855 ± 0.421 | 3.027 ± 0.659 | 3.057 ± 0.663 |
| Longest vertical line | 10.377 ± 3.110 | 10.727 ± 3.176 | 11.475 ± 3.545 |
| Recurrence time type 1 | 15.006 ± 1.912 | 14.526 ± 1.932 | 15.338 ± 3.702 |
| Recurrence time type 2 | 29.527 ± 8.291 | 29.841 ± 11.568 | 30.522 ± 10.708 |
* p < 0.05 supine position vs. active standing (same group). & p < 0.05 ESRD group (either before hemodialysis or after hemodialysis) vs. healthy group (same position).
Pearson’s correlation coefficients between meanNN and linear indices of heart rate variability in short-term electrocardiogram (ECG) recordings. The estimation of each correlation coefficient (r) includes data obtained at both the supine position and during active standing. LFnu: negative correlation, HFnu: positive correlation.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | ||||
|---|---|---|---|---|---|---|
| r | R | R | ||||
| Statistical indices | ||||||
| SDNN | 0.545 | <0.001 | 0.475 | <0.001 | 0.453 | <0.001 |
| SDSD | 0.764 | <0.001 | 0.448 | <0.001 | 0.665 | <0.001 |
| pNN50 | 0.672 | <0.001 | 0.524 | <0.001 | 0.768 | <0.001 |
| Spectral indices | ||||||
| LFnu | −0.366 | 0.004 | −0.223 | 0.093 | −0.627 | <0.001 |
| HFnu | 0.385 | 0.002 | 0.245 | 0.063 | 0.645 | <0.001 |
| LF/HF | −0.122 | 0.351 | −0.232 | 0.079 | −0.43 | 0.001 |
| Ln (LF/HF) | −0.339 | 0.008 | −0.269 | 0.041 | −0.609 | <0.001 |
Pearson’s correlation coefficients between meanNN and recurrence quantitative analysis (RQA) indices of short-term ECG recordings. The estimation of each correlation coefficient includes data obtained at both the supine position and during active standing. The recurrence plots were reconstructed with the subgroup embedding time delays, as described in the Methods section.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | ||||
|---|---|---|---|---|---|---|
| R | R | R | ||||
| Determinism | −0.452 | <0.001 | −0.256 | 0.052 | −0.485 | <0.001 |
| Mean diagonal length | −0.387 | 0.002 | −0.272 | 0.039 | −0.478 | <0.001 |
| Longest diagonal line | −0.416 | 0.001 | −0.286 | 0.029 | −0.412 | 0.001 |
| Entropy | −0.489 | <0.001 | −0.342 | 0.009 | −0.619 | <0.001 |
| Laminarity | −0.485 | <0.001 | −0.220 | 0.097 | −0.477 | <0.001 |
| Trapping time | −0.574 | <0.001 | −0.312 | 0.017 | −0.608 | <0.001 |
| Longest vertical line | −0.751 | <0.001 | −0.466 | 0.000 | −0.836 | <0.001 |
| Recurrence time type 1 | −0.163 | 0.214 | 0.080 | 0.548 | 0.230 | 0.082 |
| Recurrence time type 2 | −0.447 | <0.001 | −0.215 | 0.106 | −0.337 | 0.010 |
Pearson’s correlation coefficients between meanNN and RQA indices of short-term ECG recordings. The estimation of each correlation coefficient includes data obtained at both the supine position and during active standing. Recurrence plots were reconstructed with the overall embedding time delay = 8.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | ||||
|---|---|---|---|---|---|---|
| r | r | r | ||||
| Determinism | −0.530 | <0.001 | −0.293 | 0.026 | −0.497 | <0.001 |
| Mean diagonal length | −0.536 | <0.001 | −0.251 | 0.057 | −0.470 | <0.001 |
| Longest diagonal line | −0.530 | <0.001 | −0.376 | 0.004 | −0.572 | <0.001 |
| Entropy | −0.575 | <0.001 | −0.347 | 0.008 | −0.570 | <0.001 |
| Laminarity | −0.507 | <0.001 | −0.231 | 0.081 | −0.483 | <0.001 |
| Trapping time | −0.582 | <0.001 | −0.284 | 0.031 | −0.570 | <0.001 |
| Longest vertical line | −0.740 | <0.001 | −0.545 | <0.001 | −0.781 | <0.001 |
| Recurrence time type 1 | 0.019 | 0.886 | 0.111 | 0.405 | 0.406 | 0.002 |
| Recurrence time type 2 | −0.432 | 0.001 | −0.227 | 0.086 | −0.310 | 0.018 |
Pearson’s correlation coefficients between meanNN and recurrence quantitative analysis indices of short-term ECG recordings. The estimation of each correlation coefficient includes data obtained at both the supine position and during active standing. The recurrence plots were reconstructed with ad hoc embedding time delays estimated for each time series, as described in the Methods section.
| Healthy | ESRD before Hemodialysis | ESRD after Hemodialysis | ||||
|---|---|---|---|---|---|---|
| r | r | r | ||||
| Determinism | 0.068 | 0.603 | −0.211 | 0.112 | −0.051 | 0.695 |
| Mean diagonal length | 0.280 | 0.030 | 0.038 | 0.775 | 0.047 | 0.727 |
| Longest diagonal line | −0.100 | 0.448 | −0.195 | 0.142 | −0.114 | 0.395 |
| Entropy | 0.255 | 0.049 | −0.013 | 0.921 | −0.056 | 0.677 |
| Laminarity | −0.441 | <0.001 | −0.231 | 0.081 | −0.380 | 0.003 |
| Trapping time | −0.496 | <0.001 | −0.378 | 0.003 | −0.497 | <0.001 |
| Longest vertical line | −0.447 | <0.001 | −0.480 | <0.001 | −0.620 | <0.001 |
| Recurrence time type 1 | −0.302 | 0.019 | −0.096 | 0.473 | −0.062 | 0.644 |
| Recurrence time type 2 | −0.488 | <0.001 | −0.284 | 0.031 | −0.361 | 0.005 |
Linear stepwise multiple regression analysis with predicted heart rate variability (HRV) indices, and as independent variables, the meanNN, active standing, end-stage renal disease (ESRD), and hemodialysis conditions. All models included the same sample size (N = 176).
| Variables | Standardized β | β (C.I.95%) | P | R2 |
|---|---|---|---|---|
| Predicted HRV index: SDNN | 0.411 | |||
| meanNN | 0.584 | 0.088 (0.070–0.106) | < 0.001 | |
| Active standing | 0.185 | 0.008 (0.003–0.013) | 0.004 | |
| ESRD condition | −0.213 | −0.011 (−0.017–0.005) | 0.001 | |
| Hemodialysis |
| |||
| Predicted HRV index: Determinism | 0.288 | |||
| meanNN | −0.354 | −0.419 (−0.588–0.249) | < 0.001 | |
| Active standing | 0.217 | 0.074 (0.027–0.120) | 0.002 | |
| ESRD condition | 0.181 | 0.073 (0.020–0.127) | 0.008 | |
| Hemodialysis |
| |||
| Predicted HRV index: Trapping time | 0.287 | |||
| meanNN | −0.392 | −2.162 (−2.952–1.372) | < 0.001 | |
| Active standing | 0.190 | 0.301 (0.083–0.519) | 0.007 | |
| ESRD condition | 0.142 | 0.301 (0.083–0.519) | 0.035 | |
| Hemodialysis |
| |||
| Predicted HRV index: Recurrence time type 2 | 0.191 | |||
| meanNN | −0.264 | −12.745 (−20.129–5.362) | 0.001 | |
| Active standing | 0.219 | 3.035 (0.998–5.072) | 0.004 | |
| ESRD condition | 0.146 | 2.412 (0.077 – 4.746) | 0.043 | |
| Hemodialysis |
| |||